CD40-CD40L interactions have been shown to be pivotal in the pathogenesis of chronic inflammatory diseases including multiple sclerosis, atherosclerosis, arthritis, lupus (SLE) and diabetes [7]. This evidence concerns the gene CD40 and systemic lupus erythematosus.